| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10593887 | Bioorganic & Medicinal Chemistry Letters | 2015 | 5 Pages |
Abstract
Based on Imatinib and GNF-2, twenty hybrid molecules (series E and P compounds), designed as novel Bcr-Abl inhibitors, were synthesized and evaluated for their antitumor activity.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Xiaoyan Pan, Jinyun Dong, Ruili Shao, Ping Su, Yaling Shi, Jinfeng Wang, Langchong He,